Ajmaline infusion during automated screening in Brugada syndrome and spontaneous Type 1 electrocardiogram unmasks non-suitability for subcutaneous implantable cardioverter-defibrillator

Tardu Özkartal, Angelo Auricchio, Giulio Conte

Research output: Contribution to journalArticlepeer-review

2 Citations (Scopus)
Original languageEnglish
Pages (from-to)1888-1889
Number of pages2
JournalEuropean Heart Journal
Issue number23
Publication statusPublished - 14 Jun 2019


  • Ajmaline/therapeutic use
  • Anti-Arrhythmia Agents/therapeutic use
  • Brugada Syndrome/drug therapy
  • Defibrillators, Implantable/adverse effects
  • Device Removal
  • Electrocardiography
  • Humans
  • Male
  • Middle Aged
  • Prosthesis Failure

Cite this